AVDL AVADEL PHARMACEUTICALS PLC Management Changes 8-K Filing 2025 - Appointments On May 13, 2025, Avadel Pharmaceuticals appointed Susan Rodriguez as the Chief Operating Officer with an annual salary of $510,000 and stock options for 300,000 shares vesting over four years. This appointment signifies a strategic move for the company as it strengthens its leadership.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC